Mike D'Ambra

As the cannabis industry moves towards potential federal regulation and rescheduling for pharmaceutical-grade production, strict adherence to biosecurity measures and microbial lab test regulations becomes critical. Rescheduling marijuana could intensify FDA oversight, necessitating comprehensive...